Press Releases

All Releases
Oct 05, 2016
AngioDynamics Reports Fiscal 2017 First Quarter Results
Q1 net sales of $88.1 million , up 5% year-over-year Q1 GAAP earnings per share of $0.04 ; non-GAAP adjusted EPS of $0.17 Q1 operating cash generation of $7.4 million FY2017 guidance remains unchanged ALBANY, N.Y. , Oct. 05, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider
Sep 21, 2016
AngioDynamics to Report Fiscal 2017 First Quarter Financial Results
ALBANY, N.Y. , Sept. 21, 2016 (GLOBE NEWSWIRE) -- AngioDynamics  (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2017 first
Apr 07, 2016
AngioDynamics Reports Fiscal 2016 Third Quarter Results
Net sales of $87.4 million , up 1% year-over-year GAAP earnings per share of $0.02 ; Non-GAAP adjusted EPS of $0.15 , up 25% year-over-year Operating cash generation of $12.4 million FY2016 financial guidance updated   ALBANY, N.Y. , April 07, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a
Mar 29, 2016
AngioDynamics to Report Fiscal 2016 Third Quarter Financial Results
ALBANY, N.Y. , March 29, 2016 (GLOBE NEWSWIRE) -- AngioDynamics  (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2016 third
Mar 07, 2016
AngioDynamics to Present at the Barclays Global Healthcare Conference
ALBANY, N.Y. , March 07, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo , President and Chief Executive Officer,
Jan 07, 2016
AngioDynamics Reports Fiscal 2016 Second Quarter Results
Net sales of $89.2 million GAAP loss of $0.01 per share; Non-GAAP adjusted EPS of $0.14 Operating cash generation of $9.6 million ALBANY, N.Y. , Jan. 07, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access,
Dec 28, 2015
AngioDynamics to Report Fiscal 2016 Second Quarter Financial Results
ALBANY, N.Y. , Dec. 28, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2016 second
Displaying 141 - 160 of 719